Document is current
Any future updates will be listed below
-
Authors
Gurevich, Alexey
Nadolski, Gregory J.
Vance, Ansar Z.
El-Ghazal, Ryan-Assaad
Cohen, Raphael
Clark, Timothy W. I.
Hung, Matthew L. https://orcid.org/0000-0001-8018-8514
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 27 August 2025
First Online: 29 September 2025
Declarations
:
: This study was approved by the University of Pennsylvania Institutional Review Board, Protocol 849689. Consent was not required for this retrospective study.
: Not applicable.
: GJN reports grants from Sirtex Medical, grants from Instylla, grants from AstraZenica, outside the submitted work. AZV reports personal fees from Becton Dickinson, personal fees from Inari, personal fees from Forge Medical, outside the submitted work. TWIC reports personal fees from Teleflex, personal fees from Merit Medical, personal fees from Becton Dickinson, personal fees and other from Forge Medical, personal fees from Boston Scientific, grants from Penumbra, personal fees from Baylis Medical, outside the submitted work; In addition, TWIC has a patent 10,220,184 licensed to Teleflex, a patent 9,333,321 licensed to Teleflex, and a patent 8,517,978 licensed to Teleflex. TWIC is the inventor of the Arrow-Clark® VectorFlow® catheter. AG, RE, RC, and MLH have no disclosures.
